Patent US3621094A successfully refreshed from Google Patents.
← Back to Patent Explorer
US3621094A Expired / Lapsed US ⏱️ 0.0 years remaining

Concentrated aqueous liquid antacid compositions containing certain phosphate and gluconate salts

Assignee: Smith Kline & French Laboratories Ltd
•
Filing: 1968-04-05
•
Granted: 1971-11-16
•
Expires: 1988-04-05
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Pharmaceutically elegant aqueous pharmaceutical suspensions having antacid and antiulcer activity comprising a high concentration of antacid and a combination of calcium phosphate monobasic and a nontoxic alkali metal or alkaline earth gluconate salt such as sodium, potassium, calcium or magnesium gluconate.

Inventors

  • 👤 David Mayron
  • 👤 Frank J Tiano

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 19:03
CPC Classifications
A; A61; A61K; A61K33/00; A61K33/42

Claims Analysis

Total Claims: 5
Claim 1
Independent Claim 13 words
The pharmaceutical composition of claim 1 wherein the gluconate salt is calcium gluconate.
Claim 2
Dependent Claim 43 words
The pharmaceutical composition of claim 1 wherein the antacid is present from about 30 percent to about 45 percent weight/volume and the monobasic calcium phosphate and calcium gluconate are each present in an amount of from about 2.0 percent to about 5.0 percent.
Claim 3
Dependent Claim 21 words
The pharMaceutical composition of claim 2 wherein the antacid is magnesium hydroxide, aluminum hydroxide, magnesium carbonate, calcium carbonate or combinations thereof.
Claim 4
Dependent Claim 22 words
The pharmaceutical composition of claim 1 in which the antacid is at least one of aluminum hydroxide, magnesium carbonate or calcium carbonate.
Claim 5
Dependent Claim 42 words
The pharmaceutical composition of claim 1 in which the essential ingredients in the aqueous vehicle comprise about 19 percent aluminum hydroxide, about 11 percent magnesium hydroxide, about 7.5 percent calcium carbonate, about 3.7percent calcium phosphate monobasic, and about 2 percent calcium gluconate.

References Cited (Backward Citations)

US3062714A Cited
US3215601A Cited
US3361769A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1974-11-15 1975-05-17 1975-11-16 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1978-11-15 1979-05-17 1979-11-16 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1982-11-15 1983-05-17 1983-11-16 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag